GenMark Diagnostics Inc.

GenMark Diagnostics Inc.

GenMark Diagnostics Inc.

Overview
Date Founded

1993

Headquarters

5964 LA PLACE COURT, SUITE 100, CARLSBAD, CA, 92008

Type of Company

Public

Employees (Worldwide)

437

Industries

Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services

Company Description

GenMark Diagnostics, Inc. engages in the provision of multiplex molecular diagnostic solutions. Its solutions include ePlex System, eSensor, Electrowetting, and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA.

Contact Data
Trying to get in touch with decision makers at GenMark Diagnostics Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Secretary, Senior Vice President & General Counsel

Senior Vice President, Corporate Accounts

Vice President, Quality, Regulatory & Clinical Affairs

Senior Account Executive

Account Executive

Corporate Controller

Director of Information Technology

Paths to GenMark Diagnostics Inc.
Potential Connections via
Relationship Science
You
GenMark Diagnostics Inc.
Owners & Shareholders
Details Hidden

Consonance Capital Management's (CCM) funds seek to deliver exceptional, uncorrelated risk adjusted returns. CCM seeks to meet this objective by focusing on investment opportunities in the publicly traded stocks of healthcare companies. The firm invests in all sub-sectors of the healthcare sector including healthcare information technology, managed care, pharmaceuticals, specialty pharmaceuticals, commercial stage biotechnology, healthcare facilities and services, medical devices and supplies, diagnostics and consumer-based healthcare companies.CCM believes the public healthcare market lends itself to an active long/short strategy. The firm focuses on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The funds also invest in other types of securities and may use a variety of investment techniques to generate profit and/or control risk. These may include participating in swaps, buying or selling futures contracts, purchasing and writing options and other derivative contracts, purchasing or selling debt instruments, and trading on margin by borrowing funds and pledging securities as collateral. CCM invests primarily in healthcare companies in the US, and on an opportunistic basis in the rest of the world.^

Details Hidden

Redmill invests in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows that healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses the fundamental research as part of their investment process. Their protocols include company financial models; market models; investment theses; and regular dialogue. Redmill’s sources include contacts with physicians; focus outside US; dialogue with companies; attendance at medical conferences; meetings with private companies; and regular dialogue within the team.

Details Hidden

G2 Investment Partners Management manages a long/short equity hedge fund that focuses on investments in small-cap companies.

Recent Transactions
Details Hidden

GenMark Diagnostics Inc. issued USD Common Stock

Details Hidden

GenMark Diagnostics Inc. issued USD Common Stock

Details Hidden

GenMark Diagnostics Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Auditor

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Underwriter

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Legal Advisor

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Managing Director

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Underwriter

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Chief Financial Officer at Biological Dynamics, Inc.

Legal Advisor

Partner at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP

Clients

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

Palex Medical SA engages in the distribution of sanitary equipment and advanced hospital solutions. The company was founded in 1955 and is headquartered in Sant Cugat del Valles, Spain.

Biotron Ltd. is a clinical stage Australian biotechnology company. It engages in developing and commercializing a novel small molecule approach that has the potential to treat a number of serious viral diseases. The company's technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus. Its proprietary primary bacterial cell-based screening platform enables rapid screening for target viroporin proteins. The company was founded in February 1999 and is headquartered in North Ryde, Australia.

Key Stats and Financials As of 2019
Market Capitalization
$1B
Total Enterprise Value
$300M
Earnings Per Share
$-0.82
Revenue
$88M
Net Profit
$-47.4M
EBITDA
$-34.5M
EBITDAMargin
-39.25%
Total Debt
$76.8M
Total Equity
$12.2M
Enterprise Value / Sales
3.41x
TEVNet Income
-6.34x
Debt TEV
0.26x
Three Year Compounded Annual Growth Rate Of Revenue
21.34%
Five Year Compounded Annual Growth Rate Of Revenue
23.53%
Political Donations
$1,000
2011
Suppliers
Illumina, Inc. Computer Software | San Diego, CA

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

California Institute of Technology Investment Services & Portfolio Management | Pasadena,

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Plexus Corp. Automobiles | Neenah, WI

Plexus Corp. engages in the provision of electronic manufacturing services. The firm partners with companies to transform concepts into branded products and deliver them to the market. It has partnerships with customers in the healthcare and life sciences; industrial and commercial; communications; and aerospace and defense market sectors. The company operates through the following geographical segments: Americas (AMER); Europe, Middle East, and Africa (EMEA); and Asia-Pacific (APAC). Plexus was founded by Peter Strandwitz, Shirani Ramin and John L. Nussbaum in 1979 and is headquartered in Neenah, WI.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Quest Diagnostics, Inc. Medical Support Services - Madison, NJ

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GenMark Diagnostics Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GenMark Diagnostics Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GenMark Diagnostics Inc..